Physician profile
Linda E Tepper
NPI 1760419188
$3,146.68
in general payments reported to CMS, 2019-2025
24 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $155 · 2021: $744 · 2022: $301 · 2023: $368 · 2024: $897 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,522.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $780.18 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $423.90 | 2021-2023 | Jardiance |
| Glaxosmithkline, LLC. | $261.89 | 2020-2025 | Shingrix, Arexvy |
| Abbvie INC. | $239.97 | 2021-2025 | Ubrelvy |
| Abbott Laboratories | $201.92 | 2019-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $186.94 | 2019-2025 | |
| Esperion Therapeutics, INC. | $149.88 | 2021 | |
| Heartflow, INC. | $140.43 | 2024 | |
| Boston Scientific Corporation | $123.83 | 2021 | |
| Pfizer INC. | $94.67 | 2021-2025 | |
| Amgen INC. | $91.70 | 2019-2024 | Prolia, Evenity |
| Biohaven Pharmaceuticals, INC. | $87.80 | 2021 | |
| Merck Sharp & Dohme LLC | $79.32 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $38.17 | 2021-2024 | Airsupra |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $34.46 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $34.13 | 2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $26.11 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.68 | 2021 | |
| Dynavax Technologies Corporation | $19.86 | 2021 | |
| Medtronic, INC. | $15.62 | 2023 | Micra |
| Amarin Pharma, INC. | $13.63 | 2019 | |
| Acerus Pharmaceuticals Corporation | $13.27 | 2022 | |
| Lilly USA, LLC | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Tepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.